Skip to main content
. 2022 Oct 27;13:1059133. doi: 10.3389/fimmu.2022.1059133

Figure 4.

Figure 4

Ltic induction or cytolytic virus activation therapy (CLVA). CLVA can make latently infected cells susceptible to antivirals ang immune recognition.